We analyzed the effect of RBM10 and RBM5 protein expression on prognosis and survival rate in breast cancer, LUAD, pancreatic cancer, and hepatocellular carcinoma by GEPIA (http://gepia.cancer-pku.cn/). Here, RBM10 is linked to hepatocellular carcinoma.